2024-12-14 01:14:35
Xi 'an Aisheng Group: It is planned to conduct a comprehensive benchmarking survey on financial and internal control according to the asset securitization standards, and the Ordnance Industry Group issued the Comprehensive Financial and Audit Services Project of Xi 'an Aisheng Technology Group Co., Ltd. on the procurement e-commerce platform. The announcement shows that the project will conduct a comprehensive benchmarking survey on the purchaser's financial and internal control situation in accordance with the asset securitization standards, put forward rationalization suggestions, and issue a best-effort report. At the same time, review the annual financial statements of the purchaser during the standardized period, and assist the purchaser to complete the annual final accounts and tax returns; Cooperate with other intermediaries in their daily work. According to the requirements, the supplier must have the audit performance of similar asset securitization projects undertaken since January 1, 2021, and the project leader must have the successful project performance signed by two or more audit reports of similar asset securitization projects. According to the data, Xi 'an Aisheng Group is one of the earliest units engaged in the development and production of UAV systems in China. In 2009, 2017 and 2019, the developed products participated in the military parade of the 60th anniversary of the National Day, the 90th anniversary of the founding of the People's Republic of China and the 70th anniversary of the National Day. In addition, Inner Mongolia No.1 Machinery Co., Ltd. (600967), which is also a subsidiary of China Ordnance Industry Group, just announced on December 7 that it plans to increase its capital with related parties. Upon completion, the company will hold 4.27% of its shares, and together with the actual controller China Ordnance Industry Group and concerted parties, it will hold 52.15% of its shares.The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.In response to Trump's tariff threat, some Canadian governors supported the "cut-off" of energy products to the United States. Canadian Prime Minister Trudeau and provincial governors held another meeting on December 11 local time to discuss the tariff threat of US President-elect Trump. After the meeting, Canadian Deputy Prime Minister and Minister of Finance Christia freeland told the media that "many governors strongly supported Canada to take strong countermeasures, and some of them took the initiative to list the key minerals and metals produced in their provinces and exported to the United States." Doug Ford, Governor of Ontario, Canada, said after the meeting that if the United States insists on imposing tariffs on Canada, Ontario will "cut off" the energy supply to the United States. He said, "We will cut off the energy supply to Michigan, New York and Wisconsin." Ford also believes that Canada needs to "prepare for the battle" and Trump's tariff will be "100%". (CCTV News)
The Hang Seng Index rose more than 1%, the Hang Seng Technology Index rose 1.47%, and the technology stocks strengthened.PETER LAMELAS was nominated by Trump as the US ambassador to Argentina.The National Green Development Fund and other companies have established ecological restoration production and investment partnerships. According to the enterprise survey APP, recently, Jiangxi Green Gold Ecological Restoration Industry Investment Partnership (Limited Partnership) was established with a capital contribution of 1 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the company is jointly owned by National Green Development Fund Co., Ltd. and Jiangxi Jinkong Investment Group Co., Ltd.
Nearly 40% of the skilled talents in Shenzhen exceed 4 million, and the total number of skilled talents in Shenzhen now reaches 4.033 million, and the proportion of skilled talents has increased to 38.5%. The team size and the proportion of skilled talents are among the highest in the country ... From the launching ceremony of the 4th Shenzhen Craftsman Week and the summary meeting of skilled talents in 2024 held recently, it was learned that the construction of high-skilled talents in Shenzhen achieved positive results in 2024, which became an important foundation for supporting Shenzhen's manufacturing and Shenzhen's innovation. (Shenzhen Special Zone Daily)The South-to-North Water Transfer Project has transferred 76.7 billion cubic meters of water to support the GDP growth of more than 16 trillion yuan in the northern region. The State Council held a press conference to introduce the tenth anniversary of the first phase of the South-to-North Water Transfer Project. Wang Daoxi, Vice Minister of the Ministry of Water Resources, said that the project has transformed the water resources advantage in the southern region into the development advantage in the northern region. Up to today, the South-to-North Water Transfer Project has transferred 76.7 billion cubic meters of water, supporting the GDP growth of more than 16 trillion yuan in the northern region.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.